Streetbeat News

Products Services

MDLZ

Mondelēz International has partnered with Lotus Bakeries to expand the Biscoff brand in India and develop co-branded chocolate products in Europe. Mondelēz will manufacture, market, distribute, and sell Lotus Biscoff in India, and the companies will create new chocolate products combining Biscoff with Cadbury, Milka, and other brands.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 5:44 am

NFLX

Netflix announced a new hot dog-eating competition, 'Chestnut vs. Kobayashi: Unfinished Beef,' featuring Joey Chestnut and Takeru Kobayashi. This event comes after Chestnut's exclusion from Nathan’s Famous contest due to a rival brand deal. The contest will be broadcast live on Netflix on Sept. 2, marking Netflix's expansion into live TV and sporting events.

Portfolio Pulse from Benzinga Neuro

June 13, 2024 | 4:16 am

DOGEUSD

SHIBUSD

Shiba Inu (SHIB) experienced a sharp decline despite a broader market rally, dropping nearly 2% in the last 24 hours. Key technical indicators, including the MACD and Momentum Indicator, signal bearish trends. Additionally, a significant drop in SHIB's burn rate and whale transaction volume further contribute to the negative outlook.

Portfolio Pulse from Aniket Verma

June 13, 2024 | 4:12 am

AAPL

Apple and OpenAI have announced a partnership to integrate ChatGPT into Apple's devices, with no initial cash payments involved. The collaboration aims to enhance Apple's AI capabilities and potentially drive user engagement and upgrades. Future revenue may come from subscription conversions. Apple is also exploring partnerships with other AI companies like Google and Anthropic.

Portfolio Pulse from Ananya Gairola

June 13, 2024 | 3:05 am

AAPL

ARM

AVGO

NVDA

TSLA

Major U.S. indices had a mixed performance on Wednesday. NVIDIA, Apple, ARM Holdings, Broadcom, and Tesla were the top stocks that gained attention. NVIDIA rose 3.55% amid AI excitement, Apple increased 2.86% after unveiling new software features, ARM Holdings surged 8.11% due to new CPI data and AI enthusiasm, Broadcom climbed 2.36% after beating earnings estimates and announcing a stock split, and Tesla gained 3.88% despite its CEO facing an insider trading lawsuit.

Portfolio Pulse from Benzinga Neuro

June 13, 2024 | 2:24 am

CANQF

GHBWF

JUSHF

PLNH

The article discusses recent leadership changes and appointments in the cannabis industry, including new leaders at the New York Office of Cannabis Management, board changes at Jushi Holdings Inc., Planet 13 Holdings Inc., and Glass House Brands Inc., and strategic additions to CanaQuest Medical Corp's executive team.

Portfolio Pulse from Jelena Martinovic

June 13, 2024 | 1:47 am

ACRHF

CCHWF

CRLBF

CURLF

GTBIF

VRNOF

Cresco Labs (OTC:CRLBF) is highlighted as a top multi-state operator (MSO) in the cannabis industry with strong financial performance and significant growth potential, especially if states like Ohio, Pennsylvania, and Florida legalize recreational cannabis. The company has shown substantial improvement in its financial metrics and is trading at an attractive valuation compared to peers.

Portfolio Pulse from Nicolás Jose Rodriguez

June 13, 2024 | 1:37 am

DJT

President Joe Biden mocked former President Donald Trump and his social media platform, Truth Social, in a tweet. Biden emphasized his ability to answer questions that Trump can't and criticized Trump's late-night rants on Truth Social. Trump owns a 57.6% stake in Truth Social's parent company, Trump Media & Technology Group Corp (NASDAQ:DJT). The tweet comes amid a heated presidential contest between Biden and Trump.

Portfolio Pulse from Benzinga Neuro

June 13, 2024 | 12:58 am

TXT

Textron Aviation is expanding its operations in Australia by modernizing facilities and increasing the availability of Cessna, Beechcraft, and Hawker parts. Premiair Aviation Maintenance, acquired by Textron in 2020, has been renamed Textron Aviation Australia Pty Ltd. to integrate fully into Textron's global service network.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 10:02 pm

AZN

AstraZeneca's FARXIGA (Dapagliflozin) has received FDA approval to improve glycemic control in pediatric patients with Type-2 Diabetes aged 10 years and older. This approval is based on positive results from the pediatric T2NOW Phase III trial.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 9:38 pm